$10.780
-0.157 (-1.46%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
HELP 相似圖表分析預測
Alphio's HELP stock price prediction model matches the current Cybin Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $11.29 (+7.54%). The 1-week path is $11.01 (+4.85%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Cybin Inc 股票嗎?
Currently, Helus Pharma (HELP) is not a good buy due to its declining price and negative financial performance. The stock is trading at $10.55, down 10.59% over the last five days and 14.71% over the last 20 days. The RSI is at 39.353, indicating bearish momentum. Furthermore, the company has reported significant net losses, with a net income of -46,995,000 CAD in Q4 2026, which raises concerns about its financial health. The main risk is the declining stock price, which has dropped from a recent high of $15.15 to its current level, reflecting a loss of investor confidence despite positive analyst ratings. Therefore, it is advisable to sell or hold off on buying until there are signs of recovery in both price and financial performance.
HELP 股價於 Wednesday 收在 $10.78,此前下跌 -1.46%
Cybin Inc (HELP) last closed at $10.5, losing -2.60%. These facts feed the 1-day and 1-week HELP price prediction above.
預測驅動因素
Cybin Inc(HELP)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
相似圖表形態
近期走勢與 HELP 最接近的股票,依相似度排序。
HELP 季節性分析
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。